sodium,4-chloro-1-hydroxybutane-1-sulfonate

We are sodium,4-chloro-1-hydroxybutane-1-sulfonate CAS:54322-20-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: sodium,4-chloro-1-hydroxybutane-1-sulfonate
CAS.NO:  54322-20-2
Synonyms:
sodium 4-chloro-1-hydroxybutane-1-sulfonate
Sodium4-chloro-1-hydroxybutanesulfonate
4-chloro-1-hydroxy-1-butane sulfonate sodium
4-chlorobutyraldehyde sodium bisulphate
4-chloro-1-hydroxybutanesulphonic acid,sodium salt

Molecular Formula: C4H8ClNaO4S
Molecular Weight:  210.61200

Physical and Chemical Properties:
Density:/
Boiling point:/
Melting point:/
Flash point:/
Refractive index: /

Specification:
Appearance:White to off-white powder
Purity:≥99%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage: Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:
Intermediates of Sumatriptan succinate CAS:103628-48-4
Intermediates of Sumatriptan CAS:103628-46-2
Intermediates of Zolmitriptan CAS:139264-17-8

sodium,4-chloro-1-hydroxybutane-1-sulfonate


Related News: There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.phthalic anhydride CAS:85-44-9 Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.2-Chloro-3,5-dibromopyridine The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers.2-cloro-4-yodopiridina CAS:153034-86-7 This includes chemical APIs.The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.

Related Products
Product Name
Trichlorovinylsilane View Details
5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid View Details
Trimethylammonium monohydrochloride Cas:593-81-7 View Details
2,2,2-Trichloroethyl chloroformate manufacturer 3-Bromo-4-fluorobenzoic Acid manufacturer N-Methyl-4-piperidinol manufacturer (-)-Dimethyl d-Tartrate manufacturer 2-Isobutyl-3-methylpyrazine manufacturer